IQ Consortium® News
August 18, 2023
IQ Model-Informed Drug Development Working Group issues open call for expert in MIDD
July 18, 2023
IQ Consortium announces its newest member, Amicus Therapeutics.
July 14, 2023
The article analyzes blinded member company survey data regarding main concerns and prior experience regarding the non-clinical evaluation of excipients, essential components within drug products.
May 25, 2023
IQ Consortium welcomes its newest member, Orion Corporation, Orion Pharma.
April 11, 2023
IQ Consortium welcomes its newest member, Moderna Therapeutics.
December 7, 2022
IQ Consortium announces 2022 IQ Recognition Award Recipients!
November 4, 2022
The Global 3Rs Awards program, a collaboration between AAALAC International and the IQ Consortium, recognizes five individuals for their significant innovative contributions in 2022.
October 19, 2022
IQ Consortium welcomes Regeneron as its newest member.
October 6, 2022
IQ CPLG Machine Intelligence Workshop biographies, speaker presentation recordings, and slides available for viewing and download.
September 30, 2022
Register to attend the October IQ CMC Summit where Brian Good, Ph.D., RAC of Eli Lilly will present on Emerging Analytics Platforms for Collaboration.
September 22, 2022
IQ Consortium is honored to announce that Pat Furlong, CEO of Parent Project Muscular Dystrophy, will present the patient perspective at the 13 October IQ Symposium.
September 20, 2022
Register to attend the October IQ CMC Summit where Lindsey Saunders Gorka, Ph.D., RAC of Pfizer will present on co-processed APIs!
September 16, 2022
The IQ Consortium is pleased to include a presentation from Venkat Koganti, Bristol Myers Squibb, on long-acting injectables versatility in delivering novel therapeutics.
September 14, 2022
IQ Consortium is pleased to include a presentation from Nagendra Chemuturi (Takeda) and Vibha Jawa (BMS), on gene-based therapies at the October IQ Symposium.
September 9, 2022
IQ Consortium is pleased to include a presentation on mRNA vaccines development from Dr. Paul Rohlfing, Pfizer, at the October IQ CMC Summit.
September 7, 2022
Take advantage of the Early bird rates now when registering to attend IQ Week in person or virtually! Discounts end on 9 September!
September 2, 2022
The IQ CMC Summit offers a holistic review of the Consortium's CMC portfolio. IQ membership is not required to attend!
September 1, 2022
The IQ Consortium invites members and non-members to gather at the IQ Symposium 2022 on 13 October.
August 30, 2022
IQ Consortium is pleased to include a presentation from Dr. Ravi Shanker, Pfizer, at the October IQ CMC Summit
August 23, 2022
IQ Consortium is proud to include Dr. Lauren Black, Distinguished Scientist at Charles River Laboratories, among its esteemed speakers at October Symposium.
August 19, 2022
Register now to attend the IQ CMC Summit in Washington, DC on 12 October!
August 17, 2022
Join us at the IQ Symposium in Washington, DC on 13 October!
August 8, 2022
IQ Consortium welcomes Idorsia as its newest member.
June 7, 2022
IQ Consortium welcomes CSL Behring as its newest member.
May 26, 2022
The IQ DILI Initiative Abnormal Baseline Working Group is seeking a volunteer with strong expertise in hepatology as well as knowledge and experience in DILI and in drug development.
April 19, 2022
IQ Consortium welcomes Xencor as the newest member.
March 31, 2022
The IQ Consortium is proud to welcome Relay Therapeutics as its newest member.
The 2022 IQ Consortium and AAALAC International Global 3Rs Awards Program is accepting applications!
February 18, 2022
This program recognizes researchers for their significant innovative contributions toward the 3Rs of animal research to advance ethical science. Apply by June 1, 2022 to submit your nomination!
February 7, 2022
The IQ Consortium welcomes the Bill and Melinda Gates Medical Research Institute and Novo Nordisk as its newest member companies.
December 1, 2021
The IQ Explorative Clinical Trials Working Group recently published a paper entitled "To blind or not to blind in human and exploratory clinical trials: Acceleration of development vs. risk of bias"
November 2, 2021
Inaugural Artificial Intelligence and Machine Learning in Pediatric Research Symposium
November 2, 2021
Congratulations to IQ/AAALAC International Global 3Rs Award Recipients!
October 27, 2021
IQ Consortium announces recipients of 2021 Recognition Awards!
September 8, 2021
Remember to register for the September 17 "Patient-centric Sampling Opportunities & Challenges for Implementation in Drug Development Programs" Symposium
September 7, 2021
IQ Consortium invites you to register for the Predictive Dissolution Models for Real-time Release Testing: Development and Implementation Virtual Workshop taking place 11-12 November 2021.
August 27, 2021
The IQ DruSafe Leadership Group and EFPIA publish the results from their collaborative survey on photosafety evaluation of pharmaceuticals after implementation of ICH S10.
August 19, 2021
The Impurities Safety Working Group recently published a paper in Regulatory Toxicology and Pharmacology on calculating non-mutagenic impurity levels.
August 11, 2021
The Green Chemistry Working Group published a paper on "Improved iGAL 2.0 Metric Empowers Pharmaceutical Scientists to Make Meaningful Contributions to United Nations Sustainable Development Goal 12."
July 22, 2021
IQ DSLG Nitrosamine Working Group has recently published a new manuscript in Organic Process Research & Development entitled "Nitrosamine Reactivity: A Survey of Reactions and Purge Processes"
IQ Regulatory Advisory Committee (RAC) publishes white paper on collaboration in the age of COVID-19
July 2, 2021
Reports from nine IQ groups spanning the pharma development lifecycle provide an important framework for the industry to support future pandemic or unmet medical needs for the patients we serve.
May 21, 2021
The IQ Drug Induced Liver Injury (IQ-DILI) Initiative invites pharma and bio tech companies to join the affiliate for 1-year trial basis.
April 28, 2021
The IQ Consortium will continue to refine the attributes that brought success in its first decade into the next with technical depth, key capabilities, and its influential presence.
April 28, 2021
IQ publishes five case studies in Pharm Tech Regulatory Sourcebook, promoting collaboration and technical groups in response to current challenges and trends in pharmaceutical industry.
April 16, 2021
Join the the IQ Statistics Leadership Group, Biostatistics/CMC Forum for Pt. 3: 30 July IQ Webinar
April 16, 2021
Join the the IQ Statistics Leadership Group, Biostatistics/CMC Forum for Pt. 2: 23 July IQ Webinar
April 16, 2021
Join the the IQ Statistics Leadership Group, Biostatistics/CMC Forum for Pt. 1: 16 July IQ Webinar
April 8, 2021
Join the the IQ QLG Control Strategy Global Harmonization Working Group for the 20 May IQ Webinar
March 22, 2021
Registration opens for 15 April IQ Webinar: A Multi-company Assessment of Submicron Particle Levels in Biotechnology-derived Protein Products
February 23, 2021
Join the the IQ TALG Cell and Gene Therapy Working Group for the 26 March IQ Webinar: Biodistribution, PK/PD and related bioanalytical considerations for AAV based Gene Therapies
February 22, 2021
Congratulations to 2020 3Rs Award Winners!
February 22, 2021
IQ Drug Product Leadership Group's Pediatric Working Group Opens Registration for Five New Webinars in 2021
February 17, 2021
Join us for "Challenges of Using Closed System Transfer Devices (CSTDs) with Biological Products" a public webinar presented by IQ Closed Systems Transfer Devices (CSTD) Working Group
February 11, 2021
Join IQ and AAPS on 25 February for Blinding in Early Clinical Development Trials Webinar
January 27, 2021
Join the The IQ Translational and ADME Sciences Leadership Group (TALG) Induction Working Group (IWG) in a public webinar series based on its two recent publications in Drug Metabolism and Disposition
January 1, 2021
IQ Consortium announces recipients of 2020 Recognition Awards
September 11, 2020
IQ BioCMC LG Subvisible Particles Working Group Case Study presents a Multi-company Assessment of Submicron Particle Levels in Biotechnology-derived Protein Products
June 5, 2020
IQ DSLG Coprocessed API Working Group presents webinar on recent perspective paper - Recent Advances in Coprocessed APIs & Proposals for Enabling Commercialization of These Transformative Technologies
June 4, 2020
Registration Opens for an IQ Quality Leadership Group webinar to help prepare for the next US FDA inspection.
May 4, 2020
IQ Drug Product Leadership Group's Pediatric Working Group Opens Registration for Five New Webinars
April 24, 2020
IQ CPLG Pediatrics Working Group Case Study - Extrapolation: A New Tool Making Pediatric Drug Development More Feasible
December 6, 2019
IQ DILI is pleased to announce their latest publication in AP&T on detection, assessment and management best practices for suspected DILI in clinical trials for adults with cholestatic liver disease.
November 8, 2019
The IQ MPS Affiliate has launched its new website. Open this story to learn more about the Affiliate and its activities.
October 23, 2019
Congratulations to the 2019 Global 3Rs Award Winners!
October 15, 2019
IQ Clinical Pharmacology, and Translational and ADME Sciences Leadership Groups participate in significant scientific exchange at US FDA OCP.
October 7, 2019
Join IQ as it celebrates the tremendous efforts of the 2019 IQ Recognition Award recipients.
September 30, 2019
IQ Consortium Clinical Pharmacology Leadership Group Meets with the Japan Pharmaceutical Manufacturers Association (JPMA) and the Pharmaceuticals and Medical Devices Agency (PDMA)
August 9, 2019
IQ DILI collaborated with Biorepository, nationwide DILI experts in industry, academia, and US FDA to develop comprehensive guidelines addressing best practices for bio specimen collection.
April 15, 2019
IQ Consortium Analytical Leadership Group's Dissolution Working Group Starts Public Webinar Series
February 27, 2019
IQ has released a series of case studies on high-impact initiatives led by IQ working groups.
January 24, 2019
The assessment tools for partner research organization animal care and use programs were developed with IQ member company and CRO input.
January 24, 2019
IQ was involved in a recent USP Workshop, Enhanced Approaches for Analytical Procedure Lifecycle.
December 13, 2018
Registration is Now Open for the 2019 IQ Symposium and Related Events
November 4, 2018
IQ Consortium Lean Stability and Risk-Based Predictive Stability Working Groups join forces at 2018 PharmSci 360
July 30, 2018
IQ is co-sponsoring USP's upcoming workshop "Enhanced Approaches for Analytical Procedure Lifecycle: An Alternative to Traditional Validation."
June 1, 2018
The iGAL developed by the IQ Green Chemistry Working Group has been featured on the cover of the May Issue of Green Chemistry.
May 21, 2018
IQ DruSafe presents on ICH multidisciplinary safety guidelines at ANVISA Workshop in Brasilia
February 9, 2018
IQ CPLG Pediatrics Working Group publishes important publication on pediatric medicines development and alternate/novel approaches for clinical trials
January 31, 2018
The IQ API LG Small Molecules Impurities Working Group publishes, "Control Strategy for Small Molecule Impurities in Antibody-Drug Conjugates," in AAPS PharmSciTech.
January 22, 2018
IQ PAT Working Group Hosts "Emerging Tools and Techniques and Their Impact Supporting Process Understanding" session at IFPAC
January 22, 2018
IQ Drug Metabolism QSP Working Group publishes in CPT Pharmacometrics & Systems Pharmacology
December 18, 2017
Download the 2017 IQ Consortium's Symposium Report to read about this year's speakers' talks and IQ's continued initiatives to bring innovation and quality to pharmaceutical development.
IQ 3Rs Leadership Group continues effort to modernize animal studies for improved clinical translata
December 1, 2017
IQ 3Rs Leadership Group continues effort to modernize animal studies for improved clinical translatability
November 30, 2017
The ALG Dissolution Working Group publishes article entitled "Approaches for Establishing Clinically Relevant Dissolution Specifications for Immediate Release Solid Oral Dosage Forms" in AAPS Journal.
November 13, 2017
IQ Consortium congratulates the 2017 winners of the Global 3Rs Award, a collaboration between IQ and AAALAC International.
October 24, 2017
Register now for the joint ASCPT/IQ Half-day Symposium and Workshop on Pediatric Drug Development: Challenges and Opportunities in Extrapolation - 21 March 2018 at the Annual ASCPT Meeting in Orlando
July 24, 2017
The first phase of the Allotrope Framework has been released for commercial use.
April 3, 2017
The article presents the results of a survey on implementation of analytical quality by design concepts by small- and large- molecule companies.
December 13, 2016
IQ Says Thank You to Outgoing Chair 2014-2016, and Welcomes New Chair and Vice-Chair 2017-2019
November 23, 2016
The IQ Green Chemistry Working Group has published a new artice in Green Chemistry in collabortion with the ACS Green Chemistry Institute Pharmaceutical Roundtable.
November 21, 2016
View a summary here of the 2016 IQ/AAALAC Global 3Rs Award Winners
September 27, 2016
A new collaborative initiative was recently formed within the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) to tackle this challenge.
August 9, 2016
IQ's Change Management Working Group has produced a white paper on how to implement a change management system in the clinical development phase of a product’s lifecycle.
August 5, 2016
The IQ Consortium has formed an 11th Leadership Group to address CMC aspects of biologic development.
August 1, 2016
Leaders of the IQ Consortium Pediatric Working Group worked with the University of Maryland, FDA, EuPFI, and PDCO to organize a pediatric formulations workshop on June 8th and 9th.
May 11, 2016
Access the 3Rs CRO Outreach Working Group Training Program
April 11, 2016
The Global 3Rs Award recognizes significant innovative contributions toward the 3Rs of animal research to advance ethical science, by any researcher in academia or industry in any area of biology.
February 5, 2016
Our February 2016 Semi-Annual Update is now available.
February 5, 2016
The Framework will accelerate data sharing activities that support the Consortium’s mission.
January 24, 2016
Our 2016 schedule includes six webinars.
January 5, 2016
Q&A for "The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential For Non-Antiarrhythmic Drugs" revised.